Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed by a tissue or cell sample.
- You are currently on, or have previously been on, an "active surveillance" plan (a watchful waiting approach instead of immediate treatment) managed at National Taiwan University Hospital (NTUH).
- You have had, or are planning to have, a prostate biopsy to check whether the cancer has grown or changed since your original diagnosis.
Who may not be able to join:
- You have already received chemotherapy, radiation therapy to the pelvic area, or hormone therapy (to lower testosterone) before a tissue sample was taken from your prostate through surgery or biopsy.
- You are not willing to sign the consent form agreeing to take part in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yeong-Shiau Pu, PhD, National Taiwan University
Phone: 886-2-23123456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Gene expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.